Toronto Cardiac Tumour Conference

Q&A with Dr. Cusimano – Program Director

2017 Conference Goal & Objectives

This programme will focus on the evaluation and treatment of primary neuroendocrine tumours of the heart. Topics will cover imaging modalities used in diagnosis, surgical options and operations, chemotherapeutic treatments and options, and pathological considerations of these rare tumours.

By the end of the conference, the participant will be able to:

• Interpret the workup of a patient with a primary neuroendocrine tumour of the heart
• Describe the characteristics that determine the cardiac lesion and know the surgical options for resection
• Know which imaging modalities are best for determination of operability and the shortcoming of one modality over another
• Describe the role of neo-adjuvent therapy and new therapies for a neuroendocrine tumour of the heart
• Identify the limitations of pathological examination